Table 3.
Treatment Response and Outcomes Data
| Patient | Dose Level | Initial Local response | Distant Metastases | Survival Status |
|---|---|---|---|---|
| 1 TJ | 1 | NR/SD | None | AWD @ 40 mo. |
| 2 ST | 1 | PR | Diffuse Mets | DOD @ 34 mo. |
| 3 LM | 1 | PR | Diffuse Mets | DOD @ 15 mo. |
| 4 SR | 1 | CR | Diffuse Mets | DOD @ 29 mo. |
| 5 MW | 1 | PR | Mets at presentation | DOD @ 6 mo. |
| 6 SR | 1 | CR | None | NED @ 26 mo. |
| 7 PH | 2/-1 | CR | None | AWD @ 26 mo. |
| 8 JD | 2/-1 | PD* | None | NED @ 27 mo. |
| 9 JB | 1A | CR | None | NED @ 24 mo. |
| 10 BS | 1A | PR | Mets at presentation | DOD @ 9 mo. |
| 11 ES | 1A | PR | Mets at presentation | DOD @ 6 mo. |
| 12 JB | 1A | NA | NA | DID/DOC @ 3 mo. |
| 13 EH | 1A | PR | Mets at presentation | DOD @ 6 mo. |
| 14 ML | 1A | PR | None | NCRM @ 9 mo. |
| 15 CN | 1A | PR | None | AWD @ 18 mo. |
| 16 UG | 1A | CR | None | AWD @ 18 mo. |
NR/SD: No Response/Stable Disease
PR: Partial Response
CR: Complete Response
PD*: Progressive Disease (one patient had PD just outside of the radiotherapy field edge)
NA: Not Assessable - one patient is not assessable or evaluable due to early (possibly treatment related) death.
AWD: Alive with Disease
DOD: Died of Disease
NED: No Evidence of (Active) Disease
DID/DOC: Died of intercurrent Disease and/or treatment Complications
NCRM: Non-cancer related mortality (one patient died of a MI while NED)